Page results
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Prime Minister Boris Johnson visited the vaccination centre at the Islington Business Design Centre yesterday.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.
File results
-
FOI/2022/0527 - Staff data in Communications department
-
FOI/2022/0528 - Interpreting and translation services (Silent Sounds tender)
-
FOI/2022/0530 - Neonatal sepsis guidance
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments